Last Updated : October 10, 2024
Details
Project Status:
In Progress
Project Line:
Health Technology Review
Project Sub Line:
Technology Review
Project Number:
HE0049-000
This report aims to estimate the impacts of providing remdesivir as an outpatient treatment for COVID-19 in Canada on health system costs and health outcomes.
The analyses presented in this report were conducted using 2022 data, which represented a year of the pandemic when a large proportion of the population in Canada was infected with COVID-19.
Projects listed as “in progress” are at various stages and points of completion. These products have different processes and timelines; therefore, the timing of posting of the final reports varies and expected completion dates may change. Find out more about Projects in Progress.
The “Projects in Progress” page on the Canada's Drug Agency website is updated on a seven- to eight-day cycle. Please be advised that there may be overlap between when a new report is posted online and when the section is updated. View our current Projects in Progress.
Last Updated : October 10, 2024